Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).

Polianova, Maria T

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). [electronic resource] - Peptides Jul 2003 - 1093-8 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0196-9781

10.1016/s0196-9781(03)00176-1 doi


Administration, Intranasal
Antiretroviral Therapy, Highly Active
Antiviral Agents--therapeutic use
CD4 Lymphocyte Count
CD8-Positive T-Lymphocytes--chemistry
Coculture Techniques
DNA, Viral--analysis
HIV Core Protein p24--analysis
HIV Infections--drug therapy
HIV-1--drug effects
Humans
Lipopolysaccharide Receptors--analysis
Macrophages--chemistry
Monocytes--chemistry
Neutrophils--chemistry
Peptide T--pharmacology
Polymerase Chain Reaction
RNA, Viral--blood
Viral Load
Virus Integration--drug effects
Virus Replication--drug effects